Cooler Heads Highlights Patient Use of FDA-Cleared Scalp Cooling Device

According to a recent LinkedIn post from Cooler Heads, the company is showcasing a patient experience using its Amma scalp cooling system during AC chemotherapy at an infusion center. The post emphasizes the device’s role in helping adult cancer patients manage treatment-related hair loss and positions Amma as an FDA-cleared option for those receiving therapy for solid tumors.

The company’s LinkedIn post highlights a real-world use case, which may signal a focus on driving patient and provider awareness for Amma in oncology care settings. For investors, this patient-centric marketing approach could support adoption and utilization, potentially expanding Cooler Heads’ addressable market within supportive cancer care if it translates into higher procedure volumes and center partnerships.